Physician profile
Stephen Nicholas Baker
NPI 1063273142
$564.69
in general payments reported to CMS, 2019-2025
13 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $105 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $161.68 | 2025 | Synchromedii, Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.46 | 2025 | Relistor |
| Collegium Pharmaceutical, INC. | $67.04 | 2025 | Belbuca, Xtampza |
| Vertex Pharmaceuticals Incorporated | $50.50 | 2025 | |
| Amgen INC. | $38.36 | 2024 | Krystexxa, Tavneos |
| Fresenius USA Marketing, INC. | $23.81 | 2024 | |
| Alnylam Pharmaceuticals INC. | $22.98 | 2025 | Givlaari |
| Tersera Therapeutics LLC | $22.55 | 2025 | Prialt |
| Mallinckrodt Hospital Products INC. | $21.96 | 2024 | Acthar |
| Alexion Pharmaceuticals, INC. | $20.37 | 2024 | Ultomiris |
| Valinor Pharma, LLC | $17.22 | 2025 | Movantik |
| Azurity Pharmaceuticals, INC. | $14.59 | 2025 | Horizant |
| Abbvie INC. | $14.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.